Innospec schedules November 3 results for Innospec stock investors

Published on 10/20/2026 at 21:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue reached USD 491.40 million, up 11.80 percent year over year. IOSP stock costs EUR 88.50 on October 20, 2026 at 9:32 p.m. CEST.

Results and valuation

Innospec will release third-quarter 2026 results on November 3, 2026.
Second-quarter revenue reached USD 491.40 million, up 11.80 percent year over year.
Innospec stock costs EUR 88.50 at Lang & Schwarz on October 20, 2026 at 9:32 p.m. CEST.

IOSP, US45768S1050, Illustration mit AI erstellt.

Innospec will release its third-quarter 2026 results on November 3, 2026, giving investors the next scheduled test after second-quarter revenue rose to USD 491.40 million. Markets Insider reported that the release will come after the market closes, followed by a conference call on November 4, 2026 at 9:00 a.m. ET. Innospec stock was trading at EUR 88.50 at Lang & Schwarz on October 20, 2026 at 9:32 p.m. CEST.

Revenue provides the earnings benchmark

Innospec's second-quarter revenue increased 11.80 percent from the year-earlier period to USD 491.40 million. The company also delivered quarterly earnings per share of USD 1.27 against a consensus estimate of USD 1.05, according to MarketBeat on October 18, 2026. That comparison gives the November report a clear numerical benchmark, while the revenue figure remains the larger operating measure.

Stock remains below its yearly high

On Nasdaq, Innospec last traded at USD 99.38 on October 20, 2026 at 3:37 p.m. ET, up 1.41 percent from the prior close of USD 97.99. The 52-week range was USD 65.51 to USD 100.48, placing the Nasdaq price USD 1.10 below the high. Trading volume reached 165,188 shares in the same session.

Valuation meets the November calendar

Innospec had a market capitalization of USD 2.4 billion and a price-to-earnings ratio of 20.34 as of October 20, 2026. The November 3 release is scheduled after market close, while the conference call is set for November 4, 2026 at 9:00 a.m. ET. The dates were published in the company's investor announcement carried by Markets Insider.

Comparison with peers

Innospec: up 1.41 percent on Nasdaq, price-to-earnings ratio 20.34, market capitalization USD 2.4 billion.

Ashland: up 0.44 percent on NYSE, price-to-earnings ratio 63.28, market capitalization USD 3.3 billion.

The Chemours Company: up 2.89 percent on NYSE, negative price-to-earnings ratio of 6.53, market capitalization USD 2.0 billion.

November is the next decision point

The scheduled release places the next material company figure on November 3, 2026. Revenue of USD 491.40 million and earnings per share of USD 1.27 from the second quarter provide the immediate comparison points for the new report.

The further course of trading is shown by the continuously updated real-time quote of Innospec stock.